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Abstract
Background
Public health action to reduce dietary salt intake has driven substantial reductions in coro-
nary heart disease (CHD) over the past decade, but avoidable socio-economic differentials
remain. We therefore forecast how further intervention to reduce dietary salt intake might
affect the overall level and inequality of CHD mortality.
Methods
We considered English adults, with socio-economic circumstances (SEC) stratified by quin-
tiles of the Index of Multiple Deprivation. We used IMPACTSEC, a validated CHD policy
model, to link policy implementation to salt intake, systolic blood pressure and CHDmortal-
ity. We forecast the effects of mandatory and voluntary product reformulation, nutrition label-
ling and social marketing (e.g., health promotion, education). To inform our forecasts, we
elicited experts’ predictions on further policy implementation up to 2020. We then modelled
the effects on CHDmortality up to 2025 and simultaneously assessed the socio-economic
differentials of effect.
Results
Mandatory reformulation might prevent or postpone 4,500 (2,900–6,100) CHD deaths in
total, with the effect greater by 500 (300–700) deaths or 85% in the most deprived than in
the most affluent. Further voluntary reformulation was predicted to be less effective and
inequality-reducing, preventing or postponing 1,500 (200–5,000) CHD deaths in total, with
the effect greater by 100 (−100–600) deaths or 49% in the most deprived than in the most
affluent. Further social marketing and improvements to labelling might each prevent or post-
pone 400–500 CHD deaths, but minimally affect inequality.
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Conclusions
Mandatory engagement with industry to limit salt in processed-foods appears a promising
and inequality-reducing option. For other policy options, our expert-driven forecast warns
that future policy implementation might reach more deprived individuals less well, limiting
inequality reduction. We therefore encourage planners to prioritise equity.
Introduction
High blood pressure is the greatest contributor to the burden of coronary heart disease (CHD)
worldwide [1] and high intakes of dietary salt (sodium) are a major contributor to high blood
pressure [2–4]. For example, Mente et al. [4] analysed a prospective study of 18 high- and low-
income countries: blood pressure increased with the amount of excreted sodium; the effect was
stronger among older adults, those with hypertension, high body mass index, and high baseline
levels of sodium excretion. Thus, reducing dietary salt intakes is at the forefront of global non-
communicable disease strategies [5,6]. The World Health Organisation (WHO) have set the
ambitious target for average intakes to fall to 5g/day by 2025, a substantial (~30%) reduction of
current consumption in high-, middle-, and low-income countries [7]. This reduction should
translate rapidly to substantial reductions in blood pressure and hence in the risk of death from
stroke and CHD [8–10]. Population forecasts therefore predict substantial disease reductions
from reducing dietary salt intake [11–13], including within the United Kingdom (UK) [14,15].
Previous policy strategies to reduce salt intakes at the population-level have targeted: (i)
individual behaviour, through health promotion, information and education; (ii) the afford-
ability and information displayed on processed foods; (iii) the amounts of salt added by indus-
try to processed foods [5]. National strategies often include all the elements above, which we
expect synergise to drive behaviour change [16]. Finland offers one exemplar for coordinated
policy action. For over 30 years, the government and advisory bodies have improved individual
awareness of the link between diet and health, nutrition labelling (to signpost healthy and
unhealthy choices) and product regulation [17]. In the last decade, the UK has also pursued a
coordinated approach, with the Change4Life awareness campaign, front-of-pack nutritional
labelling, and the Responsibility Deal framework to support industry in producing healthier
products [18–20].
Concurrently, salt intakes in the UK have fallen by an average 1.4 g/day since 2001, reach-
ing 8.1 g/day in 2011 [20–22]. This has brought substantial disease reductions [23]. However,
consumption still remains above the UK government’s target of 6 g/day and the WHO’s tar-
get of 5 g/day. Furthermore, significant socio-economic differentials in salt intakes remain
(9% higher in manual worker compared with non-manual) [24]. Of concern is that socio-
economic differentials in consumption do not appear to have narrowed over a decade of pol-
icy action [25]. For the United States, Bibbins-Domingo et al. [11] forecast that reductions in
dietary salt intakes will also substantially reduce health inequalities. The public health com-
munity is therefore asking why inequality has not fallen, and how future action might be
both effective and inequality-reducing.
New public health policies are therefore encouraged to more stringently assess how they
might affect inequality [26]. This imperative to reduce socio-economic differentials was solidi-
fied by the 2010 Marmot review in the UK, which identified inequalities in diet as a key policy
target [27]. Marmot emphasised that for success, the implementation of new interventions
must have sufficient reach to all socio-economic groups.
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However, in the design of interventions, doubt remains about how to reduce inequality most
effectively. Recent theoretical analyses have distinguished interventions by the extent to which
they are “structural”, by affecting our food environment, or “agentic”, by reliance on individual
choice [28,29]. It appears that structural interventions, such as legislative and fiscal changes,
tend to be both effective and inequality-reducing. However, a survey of policymakers in four-
teen European countries indicated that most see achieving structural options as politically chal-
lenging [30]. Thus, agentic policy options are politically more likely, even though policymakers
and academics agree that they have fewer benefits, and potentially widen inequality [31,32].
New assessments are therefore needed urgently to understand the potential overall effect
and socio-economic differential of further action. We extend the validated IMPACTSEC CHD
policy model [33,34] to investigate how structural and agentic options might affect dietary salt
intakes, and how inequality in effects might arise. As we will see, our model makes use of popu-
lation survey data, published effect-sizes and expert-derived forecasts to project policy out-
comes. We used it to forecast the potential impact on English adults of policies implemented
during the 2015 UK parliament, projecting the health consequences to 2025.
Methods
We extended the validated IMPACTSEC CHD policy model for England [33,34]—a causal,
deterministic, epidemiological model—to forecast up to 2025. Socio-economic circumstances
(SEC) were measured by the English Index of Multiple Deprivation (IMD) [35]. The IMD sum-
marises individual and community characteristics within Lower layer Super Output Areas
(LSOAs) of approximately 1500 people. Based on the IMD, LSOAs were divided evenly among
five quintiles; quintile one is the most affluent, and quintile five the most deprived.
We modelled a chain of links from further policy action to average daily salt intake, to sys-
tolic blood pressure (SBP), to the rate of death from CHD (codes 410–414 in the 9th, and I20–
I25 in the 10th International Classification of Disease), stratified by IMD quintile, sex and age.
Outcomes were the overall population effect, and the inequality in this effect, on the cumulative
numbers of CHD deaths prevented or postponed, and the consequent life years gained up to
2025. We provide full model details in S1 Appendix.
Policy modelling
We forecast how four policy options might further the reduction of salt intakes, over and above
the progress on reducing dietary salt intakes already made by 2015:
1. The mandatory reformulation of processed-foods to reduce salt.
2. Further voluntary reformulation, which is dependent on the cooperation of specific
companies.
3. Further individual-targeted social marketing, promotion and education around health and
healthy eating.
4. Better labelling of product nutritional content, e.g., through front-of-pack traffic-light
labels.
We modelled the policy effects on dietary salt intake in three steps, illustrated in Fig 1. We
based our framework on the staircase analogy of Tugwell et al. [36]. In it, we define the steps:
1. Efficacy, the largest potential effect on dietary salt intake.
2. Coverage, the spread of the intervention through the population (the proportion of individ-
uals reached by policy implementation).
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3. Impact, the size of the outcome that results, if the intervention reaches its target (a propor-
tion of the largest potential effect).
These steps combine to equal the effect on consumption. Importantly, socio-economic dif-
ferentials can arise at each step and aggregate to the differential in the ultimate effect on
consumption.
Structural, reformulation options: Efficacy, Coverage and Impact
For product reformulation, efficacy was the amount of salt (g/day) that individuals obtain from
processed (including ultra-processed) foods. We estimated this value for each age, sex and
IMD quintile in two-stages: (1) we estimated overall daily salt intakes from the 2010 Health
Survey for England (HSE) (Fig 2A); (2) we then multiplied these intakes by the proportion
derived from processed-foods, estimated from the 2011 Living Costs and Food Survey (LCFS).
In this second stage, estimates were stratified by age only: 35–44 years, 0.66; 45–54 years, 0.68;
55–64 years, 0.69; 65–74 years, 0.69; 75+ years, 0.68. Compared to more general estimates [39],
these values appear conservative.
Coverage and impact were respectively the proportion of products that saw some reformu-
lation, and the consequent proportional salt reduction achieved. For mandatory reformulation,
we designed a scenario where all products were reformulated (i.e., coverage = 1) and then
investigated average reductions in salt content of 30% and 10% (i.e., impact = 0.3 or 0.1). Our
forecast of voluntary reformulation was informed by experts’ forecasts of coverage and impact,
as we outline below.
Agentic, information-provision options: Efficacy, Coverage and Impact
For social marketing and nutrition labelling, efficacy was set at an average reduction in salt
intakes of 2.39 g/day (95% Confidence Interval, 1.48 to 3.31 g/day). This is the effect after 3 to
36 months of receiving dietary advice, from a Cochrane systematic review and meta-analysis
[40]. Whilst the effect of individualised advice is likely to be stronger than from population
Fig 1. Steps to policy effects.Wemodelled the steps to the effect of an intervention on dietary salt intakes in terms of: Efficacy, the largest potential effect;
Coverage, the spread of the intervention through the population; Impact, the size of the outcome that results, if the intervention reaches its target, considering
industry or individual responsiveness. We developed this model based on the discussion surrounding McLaren et al. [29] who followed Giddens’ [37]
description of society by distinguishing structural from agentic policy options. We further applied Tugwell et al.’s [36] concept that socio-economic differentials
could arise at each step of policy action. In doing so, we expand the policy detail in Diderichsen et al.’s [38] description of the maintenance of inequality.
doi:10.1371/journal.pone.0127927.g001
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information campaigns, this is the best available data on an agentic intervention. We used it as
the upper-limit to the effects on consumption.
The final effects of social marketing and nutrition labelling depended on their coverage and
impact. Coverage was the proportion of individuals exposed to further social marketing and
nutrition labelling; we defined an adult as exposed if they receive and understand a message
sufficiently that they might persistently reduce consumption. We obtained forecasts of future
coverage from our sample of experts. We defined impact as the proportion of the maximum
possible reduction, i.e., as the proportion of the above value of efficacy, realised on average
Fig 2. Socio-economic differentials. Baseline data for adults over 35 years, stratified by Index of Multiple
Deprivation quintile: (A) dietary salt intake (g/day), converted from sodium per litre of urine recorded from the
2010 Health Survey for England; (B) the proportion of individuals with hypertension, i.e., blood pressure
greater than or equal to 140/90 mmHg, from the 2011 Health Survey for England; (C) CHD death rates per
100,000 individuals (crude). Error bars show plus and minus one standard error around the mean estimates.
See S1 Appendix.
doi:10.1371/journal.pone.0127927.g002
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among the individuals reached. However, we had no data on this proportion, and so estimated
our model at fixed values of 0.5 and 0.1.
Socio-economic differentials in the effects of interventions
There is a paucity of studies on socio-economic differentials in effects of dietary interventions
[41,42]. The reference set for different types of intervention is therefore small. This was
highlighted recently by McGill et al. [41], in an update of the systematic review by Oldroyd
et al. [42] of inequalities in the outcomes of healthy eating interventions. They found that the
majority of studies screened did not explore socio-economic differentials. Agentic interven-
tions (health promotion/information provision) appeared to have either a neutral or widen-
ing effect on inequalities. Structural interventions, which generally addressed the
affordability and availability of healthy choices, tended to narrow inequalities. However,
among the structural interventions only one addressed product reformulation. This study
evaluated the UK’s policy action to reduce salt intake, which apparently has not had a detect-
able effect on socio-economic differentials [22,25].
We therefore also asked our sample of experts to anticipate the socio-economic differentials
in future coverage and impact for voluntary reformulation, and in future coverage for social
marketing and nutrition labelling.
Forecasts of policy implementation by expert elicitation
We purposively selected a set of experts who shared a common involvement in research relat-
ing to the health-harms of dietary salt intake, and in the promotion of public health action to
reduce dietary salt intakes (see S2 Appendix for further information on our expert elicitation).
Each of our experts had published in the peer-reviewed academic literature on topics relevant
to dietary salt intake and health, and many are active at the science–policy interface in this
area. Their expertise was therefore mainly “substantive”, i.e., having an understanding of the
general problem area, rather than “normative”, e.g., expertise in the processes of policy making,
manufacturing or marketing.
Our initial sample contained 25 experts who (on 23rd January 2014) were each emailed a
brief introduction to our project together with an invitation to remotely complete a
questionnaire survey. Those who agreed were then emailed the questionnaire (S3 Appendix),
with a request to add annotations where they felt appropriate. Ethical approval was obtained
from the Chair of the Ethics Committee of the Institute of Psychology, Health and Society,
University of Liverpool (Reference: IPHS-1314-LB-267).
Our approach to expert elicitation focused on eliciting experts’ full range of uncertainty
about future developments. We therefore asked each expert to provide “your best estimate, and
also to suggest the absolute minimum value and maximum which you think could be true,
include all possibilities except those that you consider extremely unlikely (less than 1%
chance)”. Each expert was unaware of the other experts’ responses. We asked the experts for
their judgements on seven questions, illustrated below.
For reformulation, we asked for future coverage with the question
“What percentage of the processed food products currently consumed by an average English
adult are likely to be reformulated to reduce salt by 2020?”
and then for future impact by asking
Salt and Health Inequality
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“In the processed foods which are reformulated to reduce salt by 2020, what percentage reduc-
tion is likely to be achieved?”
For the agentic options, we first asked our experts to assume that coverage was currently
10%. The question we posed was
“Assuming that 10% of the entire population of adults are currently sufficiently exposed to
messages for persistent behaviour change, what is this percentage likely to be in 2020?”
Then for socio-economic differentials, we elicited a linear differential across IMD quintiles
by the question
“If the value of your estimate was represented by 1.0 in the richest, what do you think would
the value be in the poorest?”
(Putting `1.0’ would mean no different, `0.2’ would mean just 20% of that in the richest.)
We received 13 completed questionnaires, with the last returned on 14th March 2014. None
declared a conflict of interest. We used PERT distributions [43] to linearly pool the experts’
judgements using probabilistic simulation (Table 1). Thus, as is recommended practice [44], all
declared expert uncertainty propagated through to our model outputs.
Linking salt intake to mortality
Baseline mortality projections. For each sex, age and IMD quintile, we forecast CHD
mortality using a Bayesian estimation of an age, period and cohort model fitted to death rates
from 1982 to 2006 [45]. We then multiplied these baseline rates by forecast population num-
bers from the Office for National Statistics (ONS).
Adjustment of baseline projections by policy effects. Link 1: Salt intake to SBP. We used
the meta-analysis of He et al. [2], who conducted a Cochrane systematic review of randomised
trials lasting at least four weeks. The relationship is a linear dose-response that is strongest in
individuals with hypertension and weakens with age. Reducing salt intake by 6 g/day might
cause SBP to fall by approximately 5.39 mmHg in adults with hypertension, and by some 2.42
mmHg in normotensive adults. Although He et al. did not investigate socio-economic varia-
tion, we weighted the effects by the prevalence of hypertension, which rises in more deprived
areas (Fig 2B).
Table 1. Expert forecasts of future policy implementation.
Policy Component Population-
average
Socio-economic
differentiala
Voluntary
reformulation
Coverage: Percentage of products reformulated 39% (9% to 82%) 0.79 (0.18 to 1.54)
Impact: Percentage salt reduction 24% (9% to 46%)
Social marketing Coverage: New percentage exposure (considering 10% as the 2015
baseline)
22% (4% to 53%) 0.45 (0.15 to 0.90)
Nutrition labelling 23% (5% to 50%) 0.47 (0.08 to 1.12)
Means and 95% prediction intervals of the changes that our experts judged would characterise policy implementation by 2020. In S2 Appendix we present
a detailed breakdown of the within and between expert variation in judgements about each parameter value.
aThe answer to the question: “If the value in the most afﬂuent is 1.00, what is the value in the most deprived? E.g., 0.90 would be a 10% decrease and
1.10 would be a 10% increase.”
doi:10.1371/journal.pone.0127927.t001
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Link 2: SBP to CHD death rates. We used age- and sex-specific hazard ratios from the PSC
meta-analysis of prospective studies [46]. Again, socio-economic variation was not investi-
gated, but since hazard ratios describe a proportional relationship, a unit reduction in SBP will
have a greater effect in more deprived groups, where CHD death rates are higher (Fig 2C).
Time lags. We incorporated two different time lags. First, we linearly phased-in the policy
effects on salt intake up to 2020. Second, we modelled the physiological lag between decreased
SBP and decreased CHD death rates. We assumed a lag of 4 years, which Kuulasmaa et al. [47]
suggest separates changes in major risk factors and coronary events, based on data from 27
MONICA populations.
The mortality outcomes. Our outcomes were the number of deaths from CHD that might
be prevented or postponed (DPPs), and the consequent life years gained. For life years gained,
we first calculated remaining life expectancy by age, sex and IMD quintile using ONS data for
2012. We then multiplied this remaining life by the numbers of deaths prevented or postponed.
We also computed premature DPPs, i.e., the number of CHD deaths averted up to age 75
years. For each metric, we report cumulative numbers from 2015 to 2025.
Quantifying socio-economic differentials in outcomes. We summarised the socio-eco-
nomic differentials in the effect of each policy option among IMD quintiles using the Slope
Index [48]. The Slope Index fits a linear gradient through the IMD-specific values and then
reports the fitted value in the most affluent quintile minus that in the most deprived quintile.
The result is therefore an indication of the absolute inequality in effects. For relative inequality,
we divided the fitted value in the most deprived by that in the most affluent; values greater
than one therefore indicate a greater effect in the most deprived. The advantage of the Slope
Index is that it uses information from all socio-economic groups, yet straightforwardly reports
inequality as a pairwise contrast between extreme groups.
Uncertainty analysis
We analysed our model in the R environment (version 3.1.0) [49]. We used a Monte Carlo sim-
ulation that took 10,000 probabilistic samples from the distributions of expert-judgement and
from the other parameters of our model for which we could quantify uncertainty. In all cases
we used the median baseline forecast. We present means and 95% prediction intervals for the
overall effects and the socio-economic differentials in effect. To show how experts’ judgements
contributed to uncertainty, we re-estimated our model using only the mean of each expert-
forecast parameter; we then calculated the percentage reduction in the 95% prediction intervals
around the effects on CHD deaths.
Results
Upstream policy effects: dietary salt intakes
By 2020, we forecast that mandatory reformulation (with a high impact, 30% reduction in salt
content) might reduce dietary salt intake by around 1.45 g/day (Table 2). Furthermore, the
effect in the most deprived quintile would exceed that in the most affluent quintile by around
14% or 0.19 g/day, thus reducing inequality (Table 2). Our forecast also indicated that manda-
tory reformulation would be more inequality-reducing than further voluntary reformulation
(Table 2). This is due to our experts’ anticipation that the future implementation of voluntary
reformulation would reach more deprived individuals less well.
The agentic options, social marketing and nutrition labelling, might be a third as effective as
voluntary reformulation, and a tenth as effective as our high impact mandatory scenario
(Table 2). Despite uncertain effects, each option tended to widen inequality. This again comes
Salt and Health Inequality
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from our experts’ anticipation that future implementation would reach more deprived individ-
uals less well.
Downstream policy effects: CHDmortality
Via the effects on SBP (Table 2), a high impact implementation of mandatory reformulation
might prevent or postpone around 4,500 CHD deaths by 2025 (Table 3). There would conse-
quently be a gain of around 44,000 life years (Table 3). In terms of premature deaths (before
age 75 years), the same scenario might prevent or postpone around 1,400 CHD deaths by 2025
(Table 3).
Fig 3 contrasts mandatory reformulation to other policy options (see also Table 3). Further
voluntary reformulation would have around a third less total effect than a high impact imple-
mentation of mandatory reformulation; it might prevent or postpone around 1,500 CHD
deaths (Fig 3) and generate around 14,000 life years (Table 3). We forecast yet smaller effects
for social marketing and nutrition labelling; each might prevent or postpone around 400–500
CHD deaths and generate around 4,000–5,000 life years.
Socio-economic differentials in mortality reduction. The y-axis in Fig 3 shows our fore-
cast socio-economic differentials in the effects of each policy option. A high impact implemen-
tation of mandatory reformulation might prevent or postpone around 85% or 500 more CHD
deaths in the most deprived than in the most affluent, reducing inequality (Table 3). Strikingly,
inequality reductions were greater at young adult ages and were therefore more evident in
terms of premature CHD deaths (Table 3). Despite more deprived quintiles having in general
lower life expectancy, inequality reductions were also amplified in terms of life-years gained
(Table 3).
Table 2. Effects on salt intake and systolic blood pressure.
Change to salt intake (g/day) Change to systolic blood pressure (mmHg)
Population-
average effect
Absolute
differential in
effect
Relative
differential in
effect
Population-
average effect
Absolute
differential of
effect
Relative
differential of
effect
Mandatory
reformulation
(impact = 0.3)
-1.45 (-1.50 to
-1.39)
-0.19 (-0.28 to
-0.11)
1.14 (1.08 to 1.21) -0.81 (-1.10 to
-0.53)
-0.10 (-0.18 to
-0.04)
1.14 (1.05 to 1.23)
Mandatory
reformulation
(impact = 0.1)
-0.48 (-0.50 to
-0.46)
-0.065 (-0.095 to
-0.035)
1.14 (1.08 to 1.21) -0.27 (-0.37 to
-0.18)
-0.035 (-0.060 to
-0.012)
1.14 (1.05 to 1.23)
Voluntary reformulation -0.48 (-1.58 to
-0.08)
0.043 (-0.333 to
0.642)
0.90 (0.21 to 1.78) -0.27 (-0.92 to
-0.04)
0.024 (-0.185 to
0.350)
0.90 (0.22 to 1.76)
Social marketing
(impact = 0.5)
-0.13 (-0.54 to
0.07)
0.093 (-0.079 to
0.518)
0.45 (0.15 to 0.90) -0.078 (-0.326 to
0.043)
0.052 (-0.045 to
0.300)
0.46 (0.15 to 0.90)
Social marketing
(impact = 0.1)
-0.027 (-0.108 to
0.014)
0.019 (-0.016 to
0.105)
0.45 (0.15 to 0.89) -0.015 (-0.066 to
0.009)
0.011 (-0.009 to
0.062)
0.46 (0.15 to 0.90)
Nutrition labelling
(impact = 0.5)
-0.16 (-0.51 to
0.06)
0.13 (-0.08 to 0.53) 0.46 (0.09 to 1.11) -0.091 (-0.311 to
0.037)
0.071 (-0.048 to
0.308)
0.47 (0.09 to 1.12)
Nutrition labelling
(impact = 0.1)
-0.031 (-0.100 to
0.013)
0.025 (-0.017 to
0.104)
0.46 (0.08 to 1.12) -0.018 (-0.061 to
0.007)
0.014 (-0.009 to
0.061)
0.48 (0.10 to 1.13)
Mean effects assessed in year 2020, with 95% prediction intervals. For mandatory reformulation, impact is the proportional reduction in the salt content of
processed foods. For social marketing and nutrition labelling, impact is the realised proportion of our speciﬁed maximum reduction in dietary salt intake.
Absolute and relative socio-economic differentials of effect are based on the Slope Index. If the ﬁtted value of the slope is d in the most deprived and a in
the most afﬂuent, then the absolute differential is a—d and the relative differential is d / a.
doi:10.1371/journal.pone.0127927.t002
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Voluntary reformulation might prevent or postpone around 49% or 100 more CHD deaths
in the most deprived than in the most affluent (Table 3), despite a minimal differential effect
on salt intake (Table 2). This was due to the pre-existing socio-economic differentials in rates
of hypertension and CHD death, which boosted the inequality-reduction. We forecast similar
effects for social marketing and nutrition labelling, although these were highly uncertain
(Tables 2 & 3).
Uncertainty analysis
Our experts’ forecasts contributed upwards of 75% of the uncertainty in effects of further vol-
untary reformulation, social marketing and nutrition labelling. Thus, whilst we could not quan-
tify all sources of uncertainty, the uncertainty in our forecast effects was dominated by
uncertainty in our experts’ predictions of future policy implementation.
Discussion
The mandatory reformulation of processed foods to reduce salt content has the potential to be
both effective and inequality-reducing. Further voluntary reformulation, being optional on the
part of industry, would still represent a substantial benefit but we forecast that it might only
modestly narrow inequality in mortality. The agentic options, further social marketing and
Table 3. Mortality effects.
Total CHD deaths prevented or
postponed
Life years gained Premature CHD deaths prevented or
postponed
Total
population
effect
Absolute
differential
in effect
Relative
differential
in effect
Total
population
effect
Absolute
differential
in effect
Relative
differential
in effect
Total
population
effect
Absolute
differential
of effect
Relative
differential
of effect
Mandatory
reformulation
(impact = 0.3)
4,467 (2,854
to 6,147)
-528 (-748 to
-325)
1.85 (1.61 to
2.14)
43,939
(29,388 to
58,750)
-8,143
(-11,031 to
-5,311)
2.75 (2.31 to
3.28)
1,351 (909
to 1,810)
-339 (-458 to
-226)
4.41 (3.58 to
5.44)
Mandatory
reformulation
(impact = 0.1)
1,502 (953
to 2,068)
-178 (-252 to
-111)
1.85 (1.60 to
2.15)
14,791
(9,843 to
19,832)
-2,746
(-3,728 to
-1,794)
2.75 (2.31 to
3.29)
455 (306 to
608)
-114 (-154 to
-76)
4.42 (3.58 to
5.50)
Voluntary
reformulation
1,474 (220
to 4,995)
-115 (-598 to
113)
1.49 (0.42 to
2.90)
14,372
(2,169 to
48,270)
-2,092
(-9,000 to
601)
2.19 (0.56 to
4.73)
438 (65 to
1,483)
-93 (-369 to
8)
3.51 (0.75 to
9.26)
Social
marketing
(impact = 0.5)
419 (-233 to
1,764)
10 (-100 to
165)
0.84 (0.34 to
1.61)
3,996
(-2,207 to
16,674)
-95 (-1,590
to 1,111)
1.08 (0.43 to
2.13)
123 (-68 to
516)
-9 (-71 to
22)
1.42 (0.53 to
2.92)
Social
marketing
(impact = 0.1)
84 (-47 to
355)
2 (-20 to 36) 0.85 (0.34 to
1.61)
780 (-442 to
3,362)
-18 (-319 to
237)
1.08 (0.43 to
2.13)
25 (-14 to
103)
-2 (-14 to 4) 1.42 (0.54 to
2.91)
Nutrition
labelling
(impact = 0.5)
489 (-194 to
1,697)
23 (-85 to
180)
0.87 (0.25 to
2.01)
4,641
(-1,791 to
15,985)
-1 (-1,423 to
1,188)
1.11 (0.31 to
2.69)
143 (-54 to
486)
-7 (-67 to
22)
1.48 (0.39 to
3.82)
Nutrition
labelling
(impact = 0.1)
98 (-38 to
334)
4 (-17 to 35) 0.88 (0.25 to
2.02)
928 (-355 to
3,121)
-2 (-291 to
235)
1.14 (0.32 to
2.71)
29 (-11 to
96)
-2 (-13 to 5) 1.51 (0.39 to
3.85)
Effects assessed cumulatively up to the year 2025, with 95% prediction intervals. For mandatory reformulation, impact is the proportional reduction in the
salt content of processed foods. For social marketing and nutrition labelling, impact is the realised proportion of our speciﬁed maximum reduction in
dietary salt intake. Absolute and relative socio-economic differentials of effect are based on the Slope Index. If the ﬁtted value of the slope is d in the most
deprived and a in the most afﬂuent, then the absolute differential is a—d and the relative differential is d / a.
doi:10.1371/journal.pone.0127927.t003
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nutrition labelling, would likely bring substantially less benefit, and with highly uncertain
effects on inequality in mortality.
Strengths and limitations
Policy modelling. The main strength of this study was our incorporation of a theory-
based model of policy action, which we combined with strong epidemiological evidence of
health effects [3], and a thorough treatment of uncertainty. The steps in our policy model, “effi-
cacy”, “coverage”, and “impact”, isolated different functional aspects of policy action. This was
useful in isolating the components of policy implementation (which we then asked experts to
forecast) from other characteristics of society that influence the ultimate policy effects on salt
intakes. We were therefore able to gain an understanding of how inequality at each step aggre-
gated to inequality in our outcomes.
However, there were also limitations. When modelling reformulation, we might have con-
sidered variation in the potential for reformulation among different types of processed food
[50]. For many products substantial room for further salt reduction exists within the technical
and safety requirements of manufacturing, e.g., for processed meats [51]. Indeed, between 2006
and 2011, changes in the salt content of UK products included decreases of 26% for conve-
nience foods, and increases of 15% for processed vegetables, whilst processed meats showed lit-
tle change [52]. There is also an agentic component to reformulation, which could modify
outcomes, e.g., if individuals detect reformulation and consequently switch products or add
discretionary salt. It may therefore be fruitful to link the effects of reformulation to individual
consumption in more detail. However, since uncertainty remains as to the quantity of dietary
Fig 3. Policy effectiveness and inequality of effect. The cumulative changes to the total number of CHD deaths from 2015 up to 2025 (x-axis). We plot
these against the socio-economic differentials in change (y-axis). Negative values for total change indicate fewer deaths. Negative values for the socio-
economic differential indicate more deaths prevented or postponed in the most deprived, i.e., a reduction of inequality. Each axis is presented on a square-
root transformed scale to better show the small effects of social marketing and nutrition labelling. Crosses indicate the 95% prediction intervals; where each
set of vertical–horizontal lines cross, these are the mean predictions of effect.
doi:10.1371/journal.pone.0127927.g003
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salt that derives from different processed foods, and the demographic variation in this quantity,
improvements to systems of data collection are also needed.
For the agentic policy options, we lacked data on individual responsiveness to the informa-
tion they receive (our “impact” parameter). Whilst we investigated the influence of this respon-
siveness in sensitivity analysis, evidence on its magnitude and inequality would be valuable. It
is concerning that an assessment of the UK’s Change4life campaign indicated that although
awareness of the campaign increased, this translated only weakly to behaviour change [53]. We
might also expect a high level of relative inequality in responsiveness [54]. Further studies of
socio-economic differentials in individual responses to interventions should therefore be a pri-
ority, especially in light of the National Institute for Health and Care Excellence recommenda-
tion that new interventions be assessed for their potential inequality of effects [26].
It is also important to acknowledge that, in practice, each policy option will fit within a
multi-component policy strategy, where policies undoubtedly interact. Our dietary salt con-
sumption is, afterall, a product of our personal agency and the structure of our environment
[29]. For example, “nudge” campaigns are likely to be enhanced by more supportive environ-
ments, e.g., by concurrent action on price, reformulation and labelling.
Use of expert forecasts. In our study, we obtained forecasts from experts because evidence
on inequalities in the effect of dietary interventions was too sparse [41,42], and studies that do
report inequalities in effect generally contain no information about the steps through which
differential outcomes arise.
In designing our expert elicitation, we expected high uncertainty, as the range of possible
future scenarios is vast and will not necessarily reflect the history of past policy outcomes. Our
approach quantified the full range of declared expert uncertainty, without subsequent discus-
sion among experts. This is in contrast to Delphi-based approaches, which aim to reach a more
precise consensus [55]. Famously, an expert-driven forecast of climate change was criticised for
projecting too certain a future, due to forecasting based on the experts’ consensus rather than
presenting the full range of expert uncertainty [56]. The advantage of our approach is therefore
that it faithfully represents expert uncertainty. Indeed, a recent review of health economics stud-
ies indicates that expert uncertainty is rarely quantified as robustly as we have done here [57].
However, the use of experts does mean that our forecast is sensitive to the characteristics of
the experts selected. All our experts shared an academic interest in promoting public health
through dietary salt reduction. Their judgements are therefore likely to differ from other pools
of experts, e.g., those with more normative expertise of the policy or industrial processes. Fur-
ther studies might therefore wish to explore the differences among expert groups, e.g., academ-
ics vs. industry. Collecting extensive qualitative data—e.g., from follow-up phone calls—would
then help interpret emergent splits in opinion. This might prove to be informative, as industry
has vested interests in future public health strategy [58], including in regard to dietary salt
intake [59]. Within industry there is also specialist technical and economic expertise, including
experts on consumer behaviour. When surveying industry experts, it may therefore be possible
to ask more detailed questions, e.g., on the future variation in reformulation to reduce salt con-
tent among different categories of processed food.
Public health implications. The principle individuals to benefit from the reformulation of
processed foods to reduce salt are the individuals who consume the most salt from processed
foods. In the UK, salt consumption tends to rise among individuals living in areas of greater
deprivation, with lower levels of education or occupational status [24]. Thus, reformulation
approaches have a natural tendency to reduce inequalities in nutrition and health.
However, two factors might mean that reformulation does not produce the expected
inequality reduction. First, either the structural or agentic aspects of society might shift over
time to produce new socio-economic differentials. For example, in Canada new inequalities in
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table-salt use have arisen [60]. Second, as our experts’ forecast indicated, reformulation might
reach certain parts of society less well. For example, if the products reformulated tend to be
consumed by more health-conscious individuals, with already low salt intakes. In this case,
mandatory reformulation is a clear pathway to increased equity.
Indeed, our forecast suggests that the persistence of socio-economic differentials in salt
intake in the UK [25] is due, in part, to a strategy of voluntary rather than mandatory reformu-
lation. Yet there is great potential for future public health action to reduce inequality, given
that implementation has sufficient reach to individuals with the highest salt-intakes. As part of
a coordinated policy strategy, featuring structural and agentic approaches, we emphasise that
mandatory reformulation would be effective and inequality-reducing. It is also likely to be the
most cost-effective option [61].
The epidemiological evidence that reductions in dietary salt intake would consequently
reduce blood pressure and mortality is now increasingly consistent, despite methodological
issues in some studies [3]. In addition to CHD, changes in salt intake are likely to affect other
diseases, such as stroke [9] and chronic kidney disease [62]. Future work might therefore aim
to model multiple disease outcomes, to more accurately represent the total and socio-economic
differential of health benefits. Interestingly, modelling inequalities in multiple aspects of health
can lead to counter-intuitive outcomes [63].
The aetiology of CHD also includes a wide array of nutrition and lifestyle factors. However,
we have modelled only one aspect of nutrition (dietary salt intake), but other aspects, e.g., potas-
sium from fruits and vegetables, likely modify the health effects of elevated salt intakes [4]. Our
outcomes may therefore differ if interventions alter nutrition in complex ways. Furthermore,
since nutritional variation among socio-economic groups is complex, covering salt, sugar, fruit
and vegetables, meat products etc. [64], more detailed modelling of nutrition might also modify
the anticipated effects on inequalities. There is therefore great potential for further research to
support the coordinated development of public health policy over multiple aspects of nutrition.
Conclusions
A policy emphasis on mandatory reformulation to reduce the salt in processed foods would
likely be an effective and inequality-reducing route to improving population health. Policy-
makers and practitioners should, however, be invited routinely to consider the impact of their
planned interventions on inequalities, perhaps using qualitative approaches [65]. If this is
done, then our forecast indicates that future national strategies to reduce salt intake will
become substantially more effective and equitable.
Supporting Information
S1 Appendix. Modelling methods.
(PDF)
S2 Appendix. Expert elicitation methods and detailed results.
(PDF)
S3 Appendix. Expert elicitation questionnaire.
(PDF)
Acknowledgments
We would like to thank the thirteen experts who completed our questionnaire. We would also
like to thank MWhitehead for comments on the manuscript. Finally, we would like to
Salt and Health Inequality
PLOS ONE | DOI:10.1371/journal.pone.0127927 July 1, 2015 13 / 17
acknowledge the development of the original IMPACTSEC model. The English SEC project was
conducted by M Bajekal and S Scholes. H Hande set up the worksheet template; S Scholes pop-
ulated the model and was its custodian; M Bajekal ensured the integrity of in/outputs and pro-
vided SEC-related methodological solutions. M O’Flaherty and N Hawkins provided support,
clinical expertise and generated the therapeutic input. The UCL team was led by R Raine, and S
Capewell co-ordinated the overall project.
Author Contributions
Conceived and designed the experiments: DG KAMGC RM PM EA SCMOF PD HB FLW
PB. Analyzed the data: DG KAMGC PM SCMOF PD PB. Wrote the paper: DG KAMGC RM
PM EA SCMOF PD HB FLW PB.
References
1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assess-
ment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions,
1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380:
2224–2260. doi: 10.1016/S0140-6736(12)61766-8 PMID: 23245609
2. He FJ, Li JF, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane
systematic review and meta-analysis of randomised trials. The BMJ. 2013; 346: f1325. doi: 10.1136/
bmj.f1325 PMID: 23558162
3. Cobb LK, Anderson CAM, Elliott P, Hu FB, Liu K, Neaton JD, et al. Methodological issues in cohort
studies that relate sodium intake to cardiovascular disease outcomes: A science advisory from the
American Heart Association. Circulation. 2014; 129: 1173–1186. doi: 10.1161/CIR.
0000000000000015 PMID: 24515991
4. Mente A, O'Donnell MJ, Rangarajan S, McQueenMJ, Poirier P, Wielgosz A, et al. Association of urinary
sodium and potassium excretion with blood pressure. New England Journal of Medicine. 2014; 371:
601–611. doi: 10.1056/NEJMoa1311989 PMID: 25119606
5. Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake.
The BMJ. 2011; 343: d4995. doi: 10.1136/bmj.d4995 PMID: 21835876
6. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-com-
municable disease crisis. Lancet. 2011; 377: 1438–1447. doi: 10.1016/S0140-6736(11)60393-0
PMID: 21474174
7. World Health Organization. Prevention of cardiovascular disease: Guidelines for assessment and man-
agement of cardiovascular risk. Geneva: World Health Organization; 2007. ISBN 978 9241547178.
8. Capewell S, O'Flaherty M. Rapid mortality falls after risk-factor changes in populations. Lancet. 2011;
378: 752–753. doi: 10.1016/S0140-6736(10)62302-1 PMID: 21414659
9. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular
disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epide-
miological studies. The BMJ. 2009; 338: b1665. doi: 10.1136/bmj.b1665 PMID: 19454737
10. Capewell S, O'Flaherty M. Can dietary changes rapidly decrease cardiovascular mortality rates? Euro-
pean Heart Journal. 2011; 32: 1187–1189. doi: 10.1093/eurheartj/ehr049 PMID: 21367835
11. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected
effect of dietary salt reductions on future cardiovascular disease. New England Journal of Medicine.
2010; 362: 590–599. doi: 10.1056/NEJMoa0907355 PMID: 20089957
12. Hendriksen MAH, Hoogenveen RT, Hoekstra J, Geleijnse JM, Boshuizen HC, van Raaij JAM. Potential
effect of salt reduction in processed foods on health. American Journal of Clinical Nutrition. 2014; 99:
446–453. doi: 10.3945/ajcn.113.062018 PMID: 24335058
13. O'Keeffe C, Kabir Z, O'Flaherty M, Walton J, Capewell S, Perry IJ. Modelling the impact of specific food
policy options on coronary heart disease and stroke deaths in Ireland. BMJ open. 2013; 3: e002837.
doi: 10.1136/bmjopen-2013-002837 PMID: 23824313
14. Scarborough P, Nnoaham KE, Clarke D, Capewell S, Rayner M. Modelling the impact of a healthy diet
on cardiovascular disease and cancer mortality. Journal of Epidemiology and Community Health.
2012; 66: 420–426. doi: 10.1136/jech.2010.114520 PMID: 21172796
15. National Institute for Health and Care Excellence. Prevention of cardiovascular disease. NICE public
health guidance 25; 2010. guidance.nice.org.uk/ph25.
Salt and Health Inequality
PLOS ONE | DOI:10.1371/journal.pone.0127927 July 1, 2015 14 / 17
16. Michie S, West R. Behaviour change theory and evidence: A presentation to Government. Health Psy-
chology Review. 2013; 7: 1–22. doi: 10.1080/17437199.2011.649445
17. Pietinen P, Mannisto S, Valsta LM, Sarlio-Lahteenkorva S. Nutrition policy in Finland. Public Health
Nutrition. 2010; 13: 901–906. doi: 10.1017/S1368980010001072 PMID: 20513258
18. Wyness LA, Butriss JL, Stanner SA. Reducing the population's sodium intake: The UK Food Standards
Agency’s salt reduction programme. Public Health Nutrition. 2012; 15: 254–261. doi: 10.1017/
S1368980011000966 PMID: 21729460
19. Shankar B, Brambila-Macias J, Traill B, Mazzocchi M, Capacci S. An evaluation of the UK Food Stan-
dards Agency’s salt campaign. Health Economics. 2013; 22: 243–250. doi: 10.1002/hec.2772 PMID:
22223605
20. He FJ, Brinsden HC, MacGregor GA. Salt reduction in the United Kingdom: A successful experiment in
public health. Journal of Human Hypertension. 2014; 28: 345–352. doi: 10.1038/jhh.2013.105 PMID:
24172290
21. Sadler K, Nicholson S, Steer T, Gill V, Bates B, Tipping S, et al. National Diet and Nutrition Survey:
Assessment of dietary sodium in adults (aged 19 to 64 years) in England; 2011.
22. Millett C, Laverty AA, Stylianou N, Bibbins-Domingo K, Pape UJ. Impacts of a national strategy to
reduce population salt intake in England: Serial cross sectional study. PLoS ONE. 2012; 7(1): e29836.
doi: 10.1371/journal.pone.0029836 PMID: 22238665
23. He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: Its relation-
ship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014; 4: e004549
doi: 10.1136/bmjopen-2013-004549 PMID: 24732242
24. Ji C, Kandala N-B, Cappuccio FP. Spatial variation of salt intake in Britain and association with socio-
economic status. BMJ Open. 2013; 3: e002246 doi: 10.1136/bmjopen-2012-002246 PMID: 23295624
25. Ji C, Cappuccio FP. Socioeconomic inequality in salt intake in Britain 10 years after a national salt
reduction programme. BMJ Open. 2014; 4: e005683 doi: 10.1136/bmjopen-2014-005683 PMID:
25161292
26. National Institute for Health and Care Excellence. Behaviour change: Individual approaches. NICE
public health guidance 49; 2014. guidance.nice.org.uk/ph49.
27. Marmot M. The social gradient in cardiovascular disease explains more than half of the mortality gap
between rich and poor. Fair Society, Healthy Lives: A Strategic Review of Health Inequalities in
England Post-2010; 2010. Available: www.marmotreview.org.
28. Capewell S, Graham H. Will cardiovascular disease prevention widen health inequalities? PLoSMed.
2010; 7(8): e1000320. doi: 10.1371/journal.pmed.1000320 PMID: 20811492
29. McLaren L, McIntyre L, Kirkpatrick S. Rose's population strategy of prevention need not increase social
inequalities in health. International Journal of Epidemiology. 2010; 39: 372–377. doi: 10.1093/ije/
dyp315 PMID: 19887510
30. Bromley H, LloydWilliams F, Orton L, O’Flaherty M, Capewell S. Identifying the most effective and cost
effective public health nutrition policy options for CVD prevention: Euroheart II Work Package 5; 2014.
Available: http://www.ehnheart.org/component/downloads/downloads/1763.html.
31. Lorenc T, Petticrew M, Welch V, Tugwell P. What types of interventions generate inequalities? Evi-
dence from systematic reviews. Journal of Epidemiology and Community Health. 2013; 67: 190–193.
doi: 10.1136/jech-2012-201257 PMID: 22875078
32. White M, Adams J, Heywood P. How and why do interventions that increase health overall widen
inequalities within populations? In: Babones SJ, editor. Social inequality and public health: Policy
Press; 2009. pp. 64–81. ISBN 978 1847423207.
33. Bajekal M, Scholes S, Love H, Hawkins N, O'Flaherty M, Raine R, et al. Analysing recent socio-eco-
nomic trends in coronary heart disease mortality in England, 2000–2007: A population modelling study.
PLoS Med. 2012; 9(6): e1001237. doi: 10.1371/journal.pmed.1001237 PMID: 22719232
34. Scholes S, Bajekal M, Norman P, O'Flaherty M, Hawkins N, Kivimäki M, et al. Quantifying policy options
for reducing future coronary heart disease mortality in England: A modelling study. PLoS ONE. 2013; 8
(7): e69935. doi: 10.1371/journal.pone.0069935 PMID: 23936122
35. Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English indices of depriva-
tion 2007. London: Department for Communities and Local Government; 2008.
36. Tugwell P, de Savigny D, Hawker G, Robinson V. Applying clinical epidemiological methods to health
equity: The equity effectiveness loop. The BMJ. 2006; 332: 358–361. doi: 10.1136/bmj.332.7537.358
PMID: 16470062
37. Giddens A. The constitution of society: Outline of the theory of structuration. Cambridge: Polity Press;
1984. ISBN 978 0520057289.
Salt and Health Inequality
PLOS ONE | DOI:10.1371/journal.pone.0127927 July 1, 2015 15 / 17
38. Diderichsen F, Evans T, Whitehead M. The social basis of disparities in health. In: Evans T, Whitehead
M, Diderichsen F, Bhuiya A, Wirth M, editors. Challenging inequalities in health: from ethics to action.
Oxford: Oxford University Press; 2001. ISBN 978 0195137408.
39. Brown IJ, Tzoulaki I, Candeias V, Elliott P. Salt intakes around the world: Implications for public health.
International Journal of Epidemiology. 2009; 38: 791–813. doi: 10.1093/ije/dyp139 PMID: 19351697
40. Rees K, Dyakova M, Wilson N, Ward K, Thorogood M, Brunner E. Dietary advice for reducing cardio-
vascular risk. The Cochrane database of systematic reviews. 2013; 12: CD002128. doi: 10.1002/
14651858.CD002128.pub5 PMID: 24318424
41. McGill R, Anwar E, Orton L, Bromley H, Lloyd-Williams F, O’Flaherty M, et al. Are interventions to pro-
mote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact.
BMC Public Health. 2015; in press.
42. Oldroyd J, Burns C, Lucas P, Haikerwal A, Waters E. The effectiveness of nutrition interventions on die-
tary outcomes by relative social disadvantage: A systematic review. Journal of Epidemiology and Com-
munity health. 2008; 62: 573–579. doi: 10.1136/jech.2007.066357 PMID: 18559438
43. Clark CE. The PERTmodel for the distribution of an activity time. Operations Research. 1962; 10:
405–406. doi: 10.1287/opre.10.3.405
44. O'Hagan A. Probabilistic uncertainty specification: Overview, elaboration techniques and their applica-
tion to a mechanistic model of carbon flux. Environmental Modelling & Software. 2012; 36: 35–48. doi:
10.1016/j.envsoft.2011.03.003
45. Guzman Castillo M, Gillespie DOS, Allen K, Bandosz P, Schmid V, Capewell S, et al. Future declines of
coronary heart disease mortality in England andWales could counter the burden of population ageing.
PLoS ONE. 2014; 9(6): e99482. doi: 10.1371/journal.pone.0099482 PMID: 24918442
46. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortal-
ity: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;
360: 1903–1913. PMID: 12493255
47. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contri-
bution of changes in classic risk factors to trends in coronary-event rates across the WHOMONICA
Project populations. Lancet. 2000; 355: 675–687. PMID: 10703799
48. World Health Organisation. Handbook on health inequality monitoring: with a special focus on low- and
middle-income countries; 2013. ISBN 978 9241548632.
49. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation
for Statistical Computing; 2014. doi: 10.1016/j.jneumeth.2014.06.019 PMID: 24970579
50. Combris P, Goglia R, Henini M, Soler LG, Spiteri M. Improvement of the nutritional quality of foods as a
public health tool. Public Health. 2011; 125: 717–724. doi: 10.1016/j.puhe.2011.07.004 PMID:
21890152
51. Desmond E. Reducing salt: A challenge for the meat industry. Meat Science. 2006; 74: 188–196. doi:
10.1016/j.meatsci.2006.04.014 PMID: 22062728
52. Eyles H, Webster J, Jebb S, Capelin C, Neal B, Ni Mhurchu C. Impact of the UK voluntary sodium
reduction targets on the sodium content of processed foods from 2006 to 2011: Analysis of household
consumer panel data. Preventive Medicine. 2013; 57: 555–560. doi: 10.1016/j.ypmed.2013.07.024
PMID: 23954183
53. Croker H, Lucas R, Wardle J. Cluster-randomised trial to evaluate the 'Change for Life' mass media/
social marketing campaign in the UK. BMC Public Health. 2012; 12: 404. doi: 10.1186/1471-2458-12-
404 PMID: 22672587
54. Drichoutis AC, Lazaridis P, Nayga RM. Nutrition knowledge and consumer use of nutritional food
labels. European Review of Agricultural Economics. 2005; 32: 93–118. doi: 10.1093/erae/jbi003
55. O’Hagan A, Buck CE, Daneshkhah A, Eiser JR, Garthwaite PH, Jenkinson DJ, et al. Uncertain judge-
ments: Eliciting expert probabilities. 2006; Chichester: JohnWiley. ISBN 9780470029992.
56. Oppenheimer M, O'Neill BC, Webster M, Agrawala S. The limits of consensus. Science. 2007; 317
(5844), 1505–1506. doi: 10.1126/science.1144831 PMID: 17872430
57. Hadorn D, Kvizhinadze G, Collinson L, Blakely T. Use of expert knowledge in health economic decision
models. International Journal of Technology Assessment in Health Care. 2014; 4: 461–468. doi: 10.
1017/S0266462314000427 PMID: 25682957
58. Stuckler D, Nestle M. Big food, food systems, and global health. PLoSMed. 2012; 9(6): e1001242. doi:
10.1371/journal.pmed.1001242 PMID: 22723746
59. Neal B, Land M-A, Woodward M. An update on the salt wars-genuine controversy, poor science, or
vested interest? Current Hypertension Reports. 2013; 15: 687–693. doi: 10.1007/s11906-013-0389-5
PMID: 24170199
Salt and Health Inequality
PLOS ONE | DOI:10.1371/journal.pone.0127927 July 1, 2015 16 / 17
60. McLaren L, Heidinger S, Dutton D, Tarasuk V, Campbell N. A repeated cross-sectional study of socio-
economic inequities in dietary sodium consumption among Canadian adults: Implications for national
sodium reduction strategies. International Journal for Equity in Health. 2014; 13: 44. doi: 10.1186/
1475-9276-13-44 PMID: 24903535
61. Collins M, Mason H, O'Flaherty M, Guzman-Castillo M, Critchley J, Capewell S. An economic evalua-
tion of salt reduction policies to reduce coronary heart disease in England: A policy modeling study.
Value in Health. 2014; 17: 517–524. doi: 10.1016/j.jval.2014.03.1722 PMID: 25128044
62. Sanghavi S, Vassalotti JA. Dietary sodium: A therapeutic target in the treatment of hypertension and
CKD. Journal of Renal Nutrition. 2013; 23: 223–227. doi: 10.1053/j.jrn.2013.01.027 PMID: 23611551
63. McLeod M, Blakely T, Kvizhinadze G, Harris R. Why equal treatment is not always equitable: The
impact of existing ethnic health inequalities in cost-effectiveness modeling. Population Health Metrics.
2014; 12: 15. doi: 10.1186/1478-7954-12-15 PMID: 24910540
64. Pechey R, Jebb SA, Kelly MP, Almiron-Roig E, Conde S, Nakamura R, et al. Socioeconomic differ-
ences in purchases of more vs. less healthy foods and beverages: analysis of over 25,000 British
households in 2010. Social Science & Medicine. 2013; 92: 22–26. doi: 10.1016/j.socscimed.2013.05.
012
65. Taylor-Robinson D, Milton B, Lloyd-Williams F, O'Flaherty M, Capewell S. Policy-makers’ attitudes to
decision support models for coronary heart disease: A qualitative study. Journal of Health Services
Research & Policy. 2008; 13: 209–214. doi: 10.1258/jhsrp.2008.008045
Salt and Health Inequality
PLOS ONE | DOI:10.1371/journal.pone.0127927 July 1, 2015 17 / 17
